Aerosol-generating otolaryngology procedures and the need for enhanced PPE during the COVID-19 pandemic: a literature review

Background Adequate personal protective equipment is needed to reduce the rate of transmission of COVID-19 to health care workers. Otolaryngology groups are recommending a higher level of personal protective equipment for aerosol-generating procedures than public health agencies. The objective of the review was to provide evidence that a.) demonstrates which otolaryngology procedures are aerosol-generating, and that b.) clarifies whether the higher level of PPE advocated by otolaryngology groups is justified. Main body Health care workers in China who performed tracheotomy during the SARS-CoV-1 epidemic had 4.15 times greater odds of contracting the virus than controls who did not perform tracheotomy (95% CI 2.75–7.54). No other studies provide direct epidemiological evidence of increased aerosolized transmission of viruses during otolaryngology procedures. Experimental evidence has shown that electrocautery, advanced energy devices, open suctioning, and drilling can create aerosolized biological particles. The viral load of COVID-19 is highest in the upper aerodigestive tract, increasing the likelihood that aerosols generated during procedures of the upper aerodigestive tract of infected patients would carry viral material. Cough and normal breathing create aerosols which may increase the risk of transmission during outpatient procedures. A significant proportion of individuals infected with COVID-19 may not have symptoms, raising the likelihood of transmission of the disease to inadequately protected health care workers from patients who do not have probable or confirmed infection. Powered air purifying respirators, if used properly, provide a greater level of filtration than N95 masks and thus may reduce the risk of transmission. Conclusion Direct and indirect evidence suggests that a large number of otolaryngology-head and neck surgery procedures are aerosol generating. Otolaryngologists are likely at high risk of contracting COVID-19 during aerosol generating procedures because they are likely exposed to high viral loads in patients infected with the virus. Based on the precautionary principle, even though the evidence is not definitive, adopting enhanced personal protective equipment protocols is reasonable based on the evidence. Further research is needed to clarify the risk associated with performing various procedures during the COVID-19 pandemic, and the degree to which various personal protective equipment reduces the risk.

[1]  J. Grotberg,et al.  Flow-induced instabilities of a mucus–serous bilayer , 1999, Journal of Fluid Mechanics.

[2]  F. Hayden,et al.  Detection of Rhinovirus, Respiratory Syncytial Virus, and Coronavirus Infections in Acute Otitis Media by Reverse Transcriptase Polymerase Chain Reaction , 1998, Pediatrics.

[3]  A. Bennett,et al.  Influenza Aerosols in UK Hospitals during the H1N1 (2009) Pandemic – The Risk of Aerosol Generation during Medical Procedures , 2013, PloS one.

[4]  T. Jordan,et al.  Occupational tuberculous infections among pulmonary physicians in training. , 1990, The American review of respiratory disease.

[5]  W. Schaffner,et al.  American College of Chest Physicians and American Association for Bronchology [corrected] consensus statement: prevention of flexible bronchoscopy-associated infection. , 2005, Chest.

[6]  D. Welling,et al.  Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies , 2020, International forum of allergy & rhinology.

[7]  Samy Rengasamy,et al.  Respirator Performance against Nanoparticles under Simulated Workplace Activities. , 2015, The Annals of occupational hygiene.

[8]  R. Shaffer,et al.  A method to determine the available UV‐C dose for the decontamination of filtering facepiece respirators , 2010, Journal of applied microbiology.

[9]  M. J. Broadhurst,et al.  Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center , 2020, medRxiv.

[10]  Min Kang,et al.  SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.

[11]  K. Kim,et al.  What Is COVID-19? , 2020, Frontiers for Young Minds.

[12]  Lidia Morawska,et al.  The mechanism of breath aerosol formation. , 2009, Journal of aerosol medicine and pulmonary drug delivery.

[13]  D. Jewett,et al.  Blood-containing aerosols generated by surgical techniques: a possible infectious hazard. , 1992, American Industrial Hygiene Association journal.

[14]  W. Anderson,et al.  Rapid evidence summary on SARS-CoV-2 survivorship and disinfection, and a reusable PPE protocol using a double-hit process , 2020, medRxiv.

[15]  R. Turner,et al.  Characterization of Aerosols Produced during Surgical Procedures in Hospitals , 1995 .

[16]  R. Wax,et al.  Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients , 2020, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[17]  COVID-19 Decontamination and Reuse of Filtering Facepiece Respirators , 2020 .

[18]  L. Meyers,et al.  Serial Interval of COVID-19 among Publicly Reported Confirmed Cases , 2020, Emerging infectious diseases.

[19]  L. Casanova,et al.  Survival of a Surrogate Virus on N95 Respirator Material , 2013, Infection Control & Hospital Epidemiology.

[20]  M. Trotter,et al.  Protection from epistaxis blood aerosol contamination: a novel use of a surgical facemask , 2003, European Archives of Oto-Rhino-Laryngology.

[21]  Benjamin J. Cowling,et al.  Influenza Virus in Human Exhaled Breath: An Observational Study , 2008, PloS one.

[22]  M. Sobsey,et al.  Coronavirus Survival on Healthcare Personal Protective Equipment , 2010, Infection Control & Hospital Epidemiology.

[23]  Kerrie Mengersen,et al.  Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities , 2009 .

[24]  P. Woo,et al.  Viral Loads in Clinical Specimens and SARS Manifestations , 2004, Emerging infectious diseases.

[25]  M. King,et al.  Clearance of mucus by simulated cough. , 1985, Journal of applied physiology.

[26]  Peter G. Smith,et al.  Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis. , 2012, American journal of respiratory and critical care medicine.

[27]  Michael S Bergman,et al.  Infrared imaging for leak detection of N95 filtering facepiece respirators: a pilot study. , 2011, American journal of industrial medicine.

[28]  G. Chowell,et al.  Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[29]  Robert B Lawrence,et al.  Comparison of Performance of Three Different Types of Respiratory Protection Devices , 2006, Journal of occupational and environmental hygiene.

[30]  Benjamin J. Cowling,et al.  Influenza virus in human exhaled breath , 2008 .

[31]  W. Sibbald,et al.  Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. , 2004, American journal of respiratory and critical care medicine.

[32]  J. Pedrosa,et al.  Influenza Infectious Dose May Explain the High Mortality of the Second and Third Wave of 1918–1919 Influenza Pandemic , 2010, PloS one.

[33]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[34]  Kristina Peterson,et al.  Hospital respiratory protection practices in 6 U.S. states: a public health evaluation study. , 2015, American journal of infection control.

[35]  P. Walshe,et al.  Mastoidectomy and Trans‐Corneal Viral Transmission , 2005, The Laryngoscope.

[36]  K. Kortright,et al.  Hydrogen Peroxide Vapor sterilization of N95 respirators for reuse , 2020, medRxiv.

[37]  F S Rosenthal,et al.  The size distribution of droplets in the exhaled breath of healthy human subjects. , 1997, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[38]  S. Kato,et al.  Study on transport characteristics of saliva droplets produced by coughing in a calm indoor environment , 2006 .

[39]  Yiu Chung Lau,et al.  Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.

[40]  T. Newsome,et al.  Exhalation of respiratory viruses by breathing, coughing, and talking , 2009, Journal of medical virology.

[41]  Khai Tran,et al.  Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review , 2012, PloS one.

[42]  Mark H. Weir,et al.  Development of a Dose‐Response Model for SARS Coronavirus , 2010, Risk analysis : an official publication of the Society for Risk Analysis.

[43]  Y. Hao,et al.  Which preventive measures might protect health care workers from SARS? , 2009, BMC public health.

[44]  J. Fernandez-Miranda,et al.  Letter: Precautions for Endoscopic Transnasal Skull Base Surgery During the COVID-19 Pandemic , 2020, Neurosurgery.

[45]  Donald E. Low,et al.  Possible SARS Coronavirus Transmission during Cardiopulmonary Resuscitation , 2004, Emerging infectious diseases.

[46]  J. Wallinga,et al.  Different Epidemic Curves for Severe Acute Respiratory Syndrome Reveal Similar Impacts of Control Measures , 2004, American journal of epidemiology.

[47]  Malik Peiris,et al.  Viral dynamics in mild and severe cases of COVID-19 , 2020, The Lancet Infectious Diseases.

[48]  J. F. Stampfer,et al.  Particle concentration in exhaled breath. , 1987, American Industrial Hygiene Association journal.

[49]  S. Park,et al.  Viral Load Kinetics of MERS Coronavirus Infection. , 2016, The New England journal of medicine.

[50]  William G. Lindsley,et al.  Measurements of Airborne Influenza Virus in Aerosol Particles from Human Coughs , 2010, PloS one.

[51]  Tze Wai Wong,et al.  Evidence of airborne transmission of the severe acute respiratory syndrome virus. , 2004, The New England journal of medicine.

[52]  K. Martinez,et al.  Aerosol exposure from an ultrasonically activated (Harmonic) device. , 1998, The Journal of the American Association of Gynecologic Laparoscopists.

[53]  Robert Garland,et al.  American College of Chest Physicians and American Association for Bronchology Consensus Statement , 2005, Chest.

[54]  C. Nathan,et al.  Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic. , 2020, JAMA otolaryngology-- head & neck surgery.

[55]  D. Bell,et al.  Human immunodeficiency virus transmission in health care settings: risk and risk reduction. , 1991, The American journal of medicine.

[56]  E. A. Mason,et al.  Graham's Laws of diffusion and effusion , 1967 .

[57]  R. Heckert,et al.  Efficacy of vaporized hydrogen peroxide against exotic animal viruses , 1997, Applied and environmental microbiology.

[58]  Rachael M. Jones,et al.  Aerosol Transmission of Infectious Disease , 2015, Journal of occupational and environmental medicine.

[59]  D. Lung,et al.  Self-contamination during doffing of personal protective equipment by healthcare workers to prevent Ebola transmission , 2018, Antimicrobial Resistance & Infection Control.

[60]  W. Wei,et al.  Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[61]  M. Martuzzi The precautionary principle: in action for public health , 2007, Occupational and Environmental Medicine.

[62]  Y. Li,et al.  Role of air distribution in SARS transmission during the largest nosocomial outbreak in Hong Kong. , 2005, Indoor air.

[63]  T. Heikkinen,et al.  Prevalence of various respiratory viruses in the middle ear during acute otitis media. , 1999, The New England journal of medicine.

[64]  Dylan H. Morris,et al.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 , 2020, The New England journal of medicine.

[65]  Tara C Smith,et al.  Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19 , 2020, mBio.